About HALBERD CORPORATION
Halberd Corporation is a company focused on developing patented extracorporeal treatments for blood-borne and neurologic diseases, including Covid-19, PTSD, CTE, and cancer. The company is listed on the OTC PINK under the ticker HALB and is engaged in research and development through partnerships and clinical trials.
Patented extracorporeal treatment for blood-borne and neurologic diseasesDevelopment of Sequential Dialysis Technique to remove pathophysiologic basis of diseasesNeuroSense AI platform for voice-based behavioral monitoring and analysisResearch and development of treatments for PTSD, CTE, cancer, and Alzheimer’s Disease
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to HALBERD CORPORATION right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.